CURE - Citizens United for Research in Epilepsy It's Time We Found a CURE CURE Epilepsy Research

Tracy Dixon-SalazarAs Associate Research Director at CURE, Dr. Tracy Dixon-Salazar is responsible for developing and executing strategies to find cures for the epilepsies. She builds and nurtures scientific research programs at CURE and oversees multiple large-scale, collaborative research projects. Working closely with experts in the field, she helps determine objectives and set priorities for CURE’s research portfolio.

Dr. Dixon-Salazar’s desire to get a PhD was inspired by her daughter, Savannah, who suffers from a type of epilepsy called Lennox-Gastaut syndrome (LGS). After 16 years of daily, unrelenting seizures, Dr. Dixon-Salazar’s research uncovered the cause of her daughter’s epilepsy and identified a precision medication therapy that has changed their lives. With more than 13 years of research experience and 17 years of nonprofit experience, Dr. Dixon-Salazar embodies the concept that patient-focused, patient-driven research is the key to meaningful medical solutions for the diseases of our time. She is a highly sought after speaker and travels worldwide to give keynote addresses and distinguished lectures.

Dr. Dixon-Salazar received her PhD in Neurobiology from University of California, San Diego where her dissertation focused on the role of immune molecules in normal brain development and synaptic plasticity. She went on to do a post-doctoral fellowship where she identified genes that underlie pediatric neurological disorders and used cell-based and animal models to discover potential precision therapeutics.

 

 

 

 

CURE CURE is a non-profit organization founded by mothers of children with epilepsy who joined forces to spearhead the search for a cure.

CURE Epilepsy
Related:     Take Action  
Andrew's Story

Andrew's Story

Read More

Chris's Story

Chris's Story

Read More

Rebecca's Story

Rebecca's Story

Read More

CURE epilepsy
Donate

Every Dollar Counts

Donate

So Many Ways You Can Help

 


CURE is driven